Migraine Treatment Optimization Questionnaire-4 (mTOQ-4)
The mTOQ‑4 is a brief four‑item patient questionnaire that screens how effectively acute migraine treatments relieve pain and restore function.
Indications for Use
Used to assess adequacy of acute migraine treatment in adults with episodic or chronic migraine and to identify suboptimal response requiring regimen change. Provides a validated, patient‑reported measure of treatment optimization; psychometric validation in >8600 patients showed strong performance in both episodic and chronic migraine (AMPP study 1 [Level III evidence]). Higher scores correlate with lower disability and better quality of life (OVERCOME cohort 2 [Level III evidence]).
Insights & Cautions
Indicates how well acute therapy restores function and relief; higher scores reflect good optimization and correlate with lower disability and better HRQoL in large observational data 1 [Level II evidence].
Useful for quickly flagging suboptimal treatment but not a diagnostic tool and not validated to guide specific drug choices.
Cautions: patient‑reported recall bias, limited sensitivity to attack‑level variability, and not designed to compare medication classes.